For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Grail, Inc.

USPTO Granted Patents = 60

CIPO Patents = 1

EPO Patents = 24

Trademarks = 10

Forward Citations = 28

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Arash Jamshidi (17 out of 24 patents)

Samuel S Gross (13 out of 13 patents)

Oliver Claude Venn (12 out of 12 patents)

4. Matthew H Larson (11 out of 11 patents)

5. M Cyrus Maher (10 out of 10 patents)

6. Kwan Chee Chan (9 out of 86 patents)

7. Yuk-Ming Dennis Lo (9 out of 75 patents)

8. Seyedmehdi Shojaee (8 out of 8 patents)

9. Rossa Wai Kwun Chiu (8 out of 80 patents)

10. Anton Valouev (8 out of 8 patents)

11. John Beausang (7 out of 7 patents)

12. Peiyong Jiang (7 out of 52 patents)

13. Darya Filippova (6 out of 6 patents)

14. Robert Abe Paine Calef (6 out of 6 patents)

15. Nick Eattock (5 out of 5 patents)

Core Competencies:

Nucleic Acid Analysis

Methylation Markers

Convolutional Neural Networks

Cancer Detection

Sequencing Library Preparation

Cell-Free DNA

Tumor Detection

RNA Analysis

Error Correction

Fragment Size Enrichment

Targeted Sequencing

Noninvasive Diagnostics

60 patents: Sort by Forward Citations

1. 12509726 - Methods of preparing dual-indexed DNA libraries for bisulfite conversion sequencing (2025-12-30),

2. 12499972 - Identifying false positive variants using a significance model (2025-12-16),

3. 12497662 - Systems and methods for tumor fraction estimation from small variants (2025-12-16),

4. 12460269 - Methods for analyzing viral nucleic acid (2025-11-04),

5. 12435375 - Methylation markers and targeted methylation probe panel (2025-10-07),

6. 12410482 - Methylation markers and targeted methylation probe panel (2025-09-09),

7. 12385037 - Enrichment of short nucleic acid fragments in sequencing library preparation (2025-08-12),

8. 12380964 - Convolutional neural network systems and methods for data classification (2025-08-05),

9. 12264364 - Methods of preparing dual-indexed DNA libraries for bisulfite conversion sequencing (2025-04-01),

10. 12247259 - Using nucleic acid size range for noninvasive cancer detection (2025-03-11),

11. 12237053 - Detecting cross-contamination in sequencing data (2025-02-25),

12. 12236346 - Systems and methods for using a convolutional neural network to detect contamination (2025-02-25),

13. 12234514 - Source of origin deconvolution based on methylation fragments in cell-free DNA samples (2025-02-25),

14. 12191000 - Systems and methods for classifying patients with respect to multiple cancer classes (2025-01-07),

15. 12100483 - Base coverage normalization and use thereof in detecting copy number variation (2024-09-24),

GRAIL, Inc. is a healthcare company focused on cancer screening and early detection. Utilizing cutting-edge technology and genomic sequencing methods, GRAIL aims to develop blood tests that can detect multiple types of cancer at an early stage. By identifying cancer in its early stages, GRAIL seeks to enable better treatment outcomes and save lives. Visit their website to learn more about their groundbreaking research and innovative approach to cancer detection.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

60 Patents

#16 in Menlo Park, CA

#1,363 in California

#5,788 in US

#11,665 in the World

Menlo Park, CA, United States of America

Grail, Inc.

Forward Citations = 28

71 inventors:

Arash Jamshidi (17 out of 24 patents)

Samuel S Gross (13 out of 13 patents)

Oliver Claude Venn (12 out of 12 patents)

4. Matthew H Larson (11 out of 11 patents)

5. M Cyrus Maher (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…